CT Healthcare Trust plc
CTHT.L
London Stock Exchange- -
GBp
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Seestrasse 16 London United Kingdom CH-8700
- IPO Date
- Dec 2, 2016
- Website
- bbhealthcaretrust.com
- Similar Companies
- Business
- CT Healthcare Trust plc (CTHT.L) is a United Kingdom-based investment trust that aims to generate absolute returns by investing in an actively managed portfolio of global healthcare equities and derivatives, with a diversified exposure across Medical Technology, Therapeutics, Diagnostics, Distributors, and related healthcare segments. The company operates as an alternative investment fund overseen by its appointed alternative investment manager, with a portfolio that includes positions in medical devices, therapeutics, diagnostics, healthcare services, and related equities, complemented by derivative strategies to manage risk and enhance returns. Headquartered in the United Kingdom, CT Healthcare Trust lists its flagship strategy as delivering risk-adjusted growth through disciplined stock selection and tactical asset allocation within the broader healthcare universe. Founding year and headquarters CT Healthcare Trust plc is established as a UK investment trust with headquarters in the United Kingdom, focusing on global healthcare equities and derivatives to achieve its investment objective. Main products and services CT Healthcare Trust plc primarily provides: investment trust shares to investors; actively managed exposure to a diversified healthcare equity portfolio; derivative-based risk management and execution strategies; periodic income via dividends as part of its total return objective; publication of investments performance and index-based benchmarking; governance and investor communications through reports and regulatory disclosures. Latest major company changes The company has undertaken governance and board changes, including retirements and new appointments to its board in 2025–2026, reflecting strategic oversight adjustments; it has announced a strategic review in 2025 to explore options for enhancing shareholder value, including potential operational or structural changes; ongoing adjustments to the portfolio and investment strategy in response to market conditions and regulatory guidance; there have been routine updates to distribution and dividend policy aligned with performance and liquidity positions. Geographic operations and markets CT Healthcare Trust plc invests globally with a healthcare-centric focus, engaging in investments across developed and emerging markets as opportunities arise; operations and shareholder communications are conducted from the UK, with investment performance reported to UK-based investors and markets. Subsidiaries and parent relationships The company operates as an investment trust under a UK-based management framework, with Columbia Threadneedle Investment Business Limited noted in public profiles as an external manager/advisor and governance partner in related documentation; CT Healthcare Trust plc itself is the reporting vehicle, with no explicit disclosed parent company beyond its management arrangement. Industry and segments Industry: Financial services; Investment trusts; Healthcare-focused investment management. Business segments are defined by the portfolio composition across healthcare equities, derivatives, and related investments, with performance attribution by sub-sectors such as Medical Technology, Diagnostics, Focused Therapeutics, and Healthcare IT. The fund targets institutional and high-net-worth investors seeking healthcare exposure and diversified beta within a single listed vehicle. Note: This description synthesizes publicly available information on CT Healthcare Trust plc (CTHT.L) and presents current structure, focus, and recent governance-like changes. For the most precise and up-to-date details, refer to company announcements and regulatory filings.